{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-089562","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2025-09-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.471417+00:00","generated_at":"2026-05-17T06:44:48.208591+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Entero Therapeutics appoints Jason D. Sawyer as Interim CEO under consulting agreement at $12,500/month","bullets":["Jason D. Sawyer appointed Interim CEO via consulting agreement with Access Alternative Group S.A., effective Sept 4, 2025.","Compensation set at $12,500 per month; agreement renewable month-to-month at Company's discretion.","Company to indemnify Sawyer as CEO to fullest extent under Delaware law; D&O insurance maintained.","Prior interim CEO appointment disclosed Sept 9; formal consulting agreement entered Sept 8."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-089562","json":"https://secwatch.observer/filing/0001104659-25-089562.json","markdown":"https://secwatch.observer/filing/0001104659-25-089562.md","text":"https://secwatch.observer/filing/0001104659-25-089562.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925089562/0001104659-25-089562-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925089562/tm2525441d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:44:48.208591+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}